eriodictyol has been researched along with dinoprostone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Chiang, W; Chung, CP; Huang, DW; Kuo, YH; Lin, YL | 1 |
Chen, Y; Shan, X; Wang, Y; Yang, G; Zhou, B | 1 |
3 other study(ies) available for eriodictyol and dinoprostone
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Identification of compounds in adlay (Coix lachryma-jobi L. var. ma-yuen Stapf) seed hull extracts that inhibit lipopolysaccharide-induced inflammation in RAW 264.7 macrophages.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Ceramides; Coix; Dinoprostone; Flavanones; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide; Plant Extracts; Seeds | 2009 |
Eriodictyol inhibits IL-1β-induced inflammatory response in human osteoarthritis chondrocytes.
Topics: Anti-Inflammatory Agents; Cell Survival; Chondrocytes; Cyclooxygenase 2; Cytokines; Dinoprostone; Flavanones; Heme Oxygenase-1; Humans; Interleukin-1beta; Matrix Metalloproteinases; Middle Aged; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Osteoarthritis; Signal Transduction | 2018 |